Manchester University said today it is expanding its pharmacogenomics program with an online graduate certificate designed for health care professionals seeking to enhance, expand and differentiate their practice.
The new program, which provides about 180 contact hours of scheduled instruction, begins in fall 2020, the university said in a statement.
Pharmacogenomics tailors an individual’s drug therapy based on his or her genetic makeup. Using the relationship between a person's genes and his or her response to a medication can optimize therapy early on and help avoid or decrease the risk of adverse drug events.
“The goal of the new graduate certificate in PGx is to provide practitioners an opportunity to optimize the care they provide their patients. We have curated a set of cutting-edge courses that will allow them to apply important foundational knowledge about PGx to their practice on day one,” said W. Thomas Smith, dean of pharmacy programs, in the statement.
Those who could benefit from the program include pharmacists, physicians, nurse practitioners, physician assistants and genetic counselors, the statement said. It said the courses could be applied toward completion of a master's degree program in pharmacogenomics.
Manchester offers an on-campus, one-year master’s degree program in pharmacogenomics, a two-year online pharmacogeomics master’s degree and a dual degree in pharmacy and pharmacogenomics. Applications, admissions requirements and related information for the graduate certificate can be found at www.manchester.edu/pgxcertificate